Citigroup’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19 Buy
22
+21
+2,100% +$20 ﹤0.01% 5578
2026
Q1
$1 Buy
+1
New +$2 ﹤0.01% 5875
2022
Q3
Hold
0
6355
2022
Q2
Sell
-5
Closed -$15.5K 6701
2022
Q1
$21K Buy
+5
New +$34K ﹤0.01% 5124
2021
Q1
Hold
0
7474
2020
Q4
Hold
0
7654
2018
Q4
Hold
0
-$8K 7848
2018
Q3
Hold
0
7416

Other funds holding VTAK

Citigroup's VTAK Position: Q2 2026 in Review

Citigroup increased its Catheter Precision (VTAK) stake by 2,100% in Q2 2026, buying an estimated $20 and bringing the position to 22 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #5578.

Citigroup first reported a position in VTAK in Q1 2022 and has held it in 3 quarters since. The position peaked at $21K in Q1 2022. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.

  • Citigroup held 22 shares of Catheter Precision worth $19 as of Q2 2026.
  • Citigroup bought 21 Catheter Precision shares in Q2 2026, an estimated $20.
  • Catheter Precision made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5578 holding.
  • Citigroup first reported a position in Catheter Precision in Q1 2022 and has held it in 3 quarters since.
  • Citigroup's Catheter Precision position peaked at $21K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.